
The question that is often asked is whether other birth defects can be identified during the first-trimester ultrasound examination of the fetus? This section will discuss the ultrasound detection of birth defects, other than chromosomal anomalies and heart defects, that have been identified during the first-trimester and the outcome of fetuses with an increased nuchal translucency that is not explained by abnormal chromosomes or congenital heart defects.
In addition to heart abnormalities, investigators have evaluated the detection of other major birth defects when fetuses have been examined during the first-trimester of pregnancy. In a study reported by Carvalho et al in 2002, they evaluated their detection rate for birth defects in 2,853 patients who underwent first-trimester ultrasound screening, with the majority returning for examinations during the second (18 to 24 weeks) and third (30 to 34 weeks) trimesters of pregnancy. From this group of patients there were 130 fetuses with either major or minor birth defects. The following is a summary of their findings;
From the above list it is evident that a second-trimester ultrasound is mandatory to identify serious birth defects that may not be identified during the first-trimester examination. For this reason, Dr. DeVore recommends the Genetic Ultrasound as an option.
The incidence of congenital heart defects have been discussed in a previous section.
In a recent study reported by Maymon et al, they found that after abnormal chromosomes and congenital heart defects had been identified, the remaining fetuses with an abnormal nuchal translucency could be categorized into two groups.